Prevalence of metabolic abnormalities in the Tunisian adults: a population based study (Q38916947)

7 September 2017

Prevalence of metabolic abnormalities in the Tunisian adults: a population based study (English)

1 reference

7 September 2017

Bouguerra R

1

1 reference

7 September 2017

Ben Salem L

2

1 reference

7 September 2017

Alberti H

3

1 reference

7 September 2017

Ben Rayana C

4

1 reference

7 September 2017

El Atti J

5

1 reference

7 September 2017

Blouza S

6

1 reference

7 September 2017

Gaigi S

7

1 reference

7 September 2017

Achour A

8

1 reference

7 September 2017

Ben Slama C

9

1 reference

7 September 2017

Zouari B

10

1 reference

7 September 2017

1 June 2006

1 reference

7 September 2017

Diabetes and Metabolism

1 reference

7 September 2017

32

1 reference

7 September 2017

3

1 reference

7 September 2017

215-221

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Metabolic syndrome: in search of a clinical role

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Metabolic syndrome among Moroccan Sahraoui adult Women

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Prevalence of the metabolic syndrome among Omani adults

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

The metabolic syndrome in the West Bank population: an urban-rural comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

The prevalence of the metabolic syndrome among arab americans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Diabetes Mellitus in Tunisia: Description in Urban and Rural Populations

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

Health and development in the Arab world: which way forward?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

The burden of type 2 diabetes: are we doing enough?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970271-9

7 January 2021

10.1016/S1262-3636(07)70271-9

Identifiers

DOI

1 reference

7 September 2017

1 reference